Back to Search Start Over

Sedentary Lifestyles and a Hypercaloric Diets During Middle Age, are Binomial Conducive to Fatal Progression, That is Counteracted by the Hormetic Treatment of Exercise, Metformin, and Tert-Butyl Hydroquinone: An Analysis of Female Middle-Aged Rat Liver Mitochondria

Authors :
Stefanie Paola López-Cervantes
Rafael Toledo-Pérez
Jaime Abraham De Lira-Sánchez
Giovanni García-Cruz
Mercedes Esparza-Perusquía
Armando Luna-López
Juan Pablo Pardo
Oscar Flores-Herrera
Mina Konigsberg
Source :
Dose-Response, Vol 22 (2024)
Publication Year :
2024
Publisher :
SAGE Publishing, 2024.

Abstract

The world’s population continuous to shift towards older, less active and more sedentary lifestyles especially during middle age. In addition consumption of high-caloric diets, increases the risk of metabolic and cardiovascular afflictions. Developing clinical strategies to mitigate those health complications represent a difficult challenge. Our group has previously shown that combining metformin (MTF) and tert-butyl hydroquinone (tBHQ) treatments, in addition to exercise, partially prevents liver damage associated with obesity. Hence, we evaluated the role of exercise in combination with MTF and tBHQ (triple-treatment) to counteract mitochondrial damage in the liver from obese middle-aged female rats. Animals were fed a high-fat diet (HFD) starting at 21 days till 15 months of age. The treated groups performed a Fartlek-type exercise 5 days/week for 30 min/session. MTF and tBHQ were administered at a dose of 250 mg/kg/day, and 10 mg/kg/day, respectively, for 7 days/month from 10 to 15 months of age. Triple-treatment therapeutic approach promoted animal survival, and increased AMPK and PGC1α expression. Treatments increased mitochondrial ATP synthesis and OXPHOS complexes activities, recovered membrane potential, and decreased ROS production. In summary, exercise in combination with intermittent tBHQ and MTF treatments proved to be an excellent intervention to prevent mitochondrial damage caused by HFD.

Subjects

Subjects :
Therapeutics. Pharmacology
RM1-950

Details

Language :
English
ISSN :
15593258
Volume :
22
Database :
Directory of Open Access Journals
Journal :
Dose-Response
Publication Type :
Academic Journal
Accession number :
edsdoj.b3181acc3f064eb4820fecde381a0e80
Document Type :
article
Full Text :
https://doi.org/10.1177/15593258241272619